Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Comparing the use of messenger ribonucleic acid and micro-ribonucleic acid to detect concussion and predict recovery time.
FY 2022-23
Summary
In concussion rehabilitation, current practices mainly involve the use of measures such as symptom checklists, cognitive and balance tests, and ultimately clinical judgement to diagnose concussions, determine management strategies, and evaluate progress of recovery. The use of subjective measures has the potential to lead to an inaccurate diagnosis. Additionally, athletes with concussion may be medically cleared to return to sport before a full physiological recovery. An emerging area of research involves the use of two types of blood biomarkers, messenger ribonucleic acid (mRNA) and micro- ribonucleic acid (miRNA), as potential objective measures. Both mRNA and miRNA impact gene expression, protein synthesis, and can offer information on thousands of genes. Following a concussion, a neurometabolic cascade is initiated resulting in the activation of various physiological/molecular processes implicated in concussion symptoms. In response, neurons alter their gene expression through miRNAs and mRNAs to off-set these pathways. Recent studies have found significant differences in various miRNA/mRNA after a concussion, and that elevated levels of certain miRNA are associated with significantly longer recovery time. These miRNA/mRNA are involved various pathways and physiological changes associated with the onset of concussion symptoms. Thus, evaluating changes in miRNA/mRNA expression would enhance the understanding of this cascade and potentially lead to better diagnostic tools for concussion. Currently it is unknown whether mRNA or miRNA would provide better understanding of the pathophysiology of concussion. Therefore, the purpose of this study is to determine whether miRNA or mRNA better detects concussion and/or predicts recovery time.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486572
Name
Ammendolia Tomé Genevieve
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Comparing the use of messenger ribonucleic acid and micro-ribonucleic acid to detect concussion and predict recovery time.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Concussion; Gene Expression; Messenger Ribonucleic Acid; Micro-Ribonucleic Acid; Mild-Traumatic Brain Injury; Pathophysiology
Abstract
In concussion rehabilitation, current practices mainly involve the use of measures such as symptom checklists, cognitive and balance tests, and ultimately clinical judgement to diagnose concussions, determine management strategies, and evaluate progress of recovery. The use of subjective measures has the potential to lead to an inaccurate diagnosis. Additionally, athletes with concussion may be medically cleared to return to sport before a full physiological recovery. An emerging area of research involves the use of two types of blood biomarkers, messenger ribonucleic acid (mRNA) and micro- ribonucleic acid (miRNA), as potential objective measures. Both mRNA and miRNA impact gene expression, protein synthesis, and can offer information on thousands of genes. Following a concussion, a neurometabolic cascade is initiated resulting in the activation of various physiological/molecular processes implicated in concussion symptoms. In response, neurons alter their gene expression through miRNAs and mRNAs to off-set these pathways. Recent studies have found significant differences in various miRNA/mRNA after a concussion, and that elevated levels of certain miRNA are associated with significantly longer recovery time. These miRNA/mRNA are involved various pathways and physiological changes associated with the onset of concussion symptoms. Thus, evaluating changes in miRNA/mRNA expression would enhance the understanding of this cascade and potentially lead to better diagnostic tools for concussion. Currently it is unknown whether mRNA or miRNA would provide better understanding of the pathophysiology of concussion. Therefore, the purpose of this study is to determine whether miRNA or mRNA better detects concussion and/or predicts recovery time.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ammendolia Tomé, Genevieve
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~